Fundz

Fundz Deep Dive

Everything you need to win epiq Animal Health and Interpath Global — in one platform.

Who to reach, what to say, and why now on epiq Animal Health and Interpath Global — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on epiq Animal Health and Interpath Global — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

epiq Animal Health and Interpath Global Partner to Bring Revolutionary Joint Health Product to US Market

Dec 16, 2024•over 1 year ago

Contract Type

partnership

United StatesHealth Care

Description

epiq Animal Health and Interpath Global have announced a strategic partnership to introduce 4CYTE™, a nutraceutical with a patented ingredient - Epiitalis®, to the animal health distribution channels in the United States. The product is scientifically proven to enhance joint health in dogs and horses, and has undergone rigorous assessments for safety and efficacy.

Company Information

Company

epiq Animal Health and Interpath Global

Location

United States

About

epiq Animal Health is a master distributor, and Interpath Global is involved in the production of the joint health product.

Predictive Intelligence
Strategic

ML-powered predictions for epiq Animal Health and Interpath Global's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.